February 28, 2018 / 9:54 PM / 7 months ago

BRIEF-Covance Enters Into Strategic Technology Agreement With GSK

Feb 28 (Reuters) - Laboratory Corporation Of America Holdings:

* COVANCE ENTERS INTO STRATEGIC TECHNOLOGY AGREEMENT WITH GSK

* LABCORP - ‍GSK WILL USE COVANCE'S XCELLERATE MONITORING, XCELLERATE INSIGHTS, XCELLERATE CLINICAL DATA HUB SOLUTIONS IN SOFTWARE-AS-A-SERVICE MODEL​

* LABCORP - ‍COVANCE DRUG DEVELOPMENT BUSINESS ENTERED INTO A STRATEGIC TECHNOLOGY AGREEMENT WITH GLAXOSMITHKLINE

* LABCORP - ‍COVANCE WILL SUPPORT GSK WITH IMPLEMENTATION, STARTING IN FIRST HALF OF 2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below